Related Experiment Video
Updated: Apr 30, 2026
07:34
Milk Collection Methods for Mice and Reeves' Muntjac Deer
Published on: July 19, 2014
19.8K
Linking Animal Feed Formulation to Milk Quantity, Quality, and Animal Health Through Data-Driven Decision-Making
Oreofeoluwa A Akintan1, Kifle G Gebremedhin2, Daniel Dooyum Uyeh1
1Department of Biosystems and Agricultural Engineering, Michigan State University, East Lansing, MI 48824, USA.
Animals : an Open Access Journal From MDPI
|January 25, 2025
Summary
Data-driven livestock feed formulation optimizes milk production and quality. This approach enhances animal health and sustainable dairy farming by integrating diverse data sources and advanced analytics.
Area of Science:
- Animal Science
- Agricultural Technology
Background:
- Growing global demand for dairy necessitates efficient livestock feed formulation.
- Modern feed formulation integrates nutritional, environmental, and animal performance data.
Purpose of the Study:
- To review advancements and challenges in data-driven feed formulation for milk quantity and quality.
- To highlight optimized feed formulation's role in sustainable dairy production.
Main Methods:
- Review of current literature on data-driven feed formulation strategies.
- Analysis of machine learning and optimization algorithms in feed optimization.
- Examination of Decision Support Systems for real-time adjustments.
Main Results:
- Data-driven approaches enhance milk yield and nutritional value.
- Tailored feed formulations improve livestock health and productivity.
- Decision Support Systems enable adaptive management for dairy operations.
Conclusions:
- Data-driven feed formulation is key to increasing milk output and quality.
- Overcoming challenges like data quality and industry adoption is crucial for sustainable dairy.
- Optimized feed strategies contribute significantly to sustainable dairy production.
Related Concept Videos
01:09Decision Making: P-value Method
5.8K
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
5.8K
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
544
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
544
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
363
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
363
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
394
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
394
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
01:28Methods of Medium Optimization
70
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
70